Sarcopenia measured by artificial intelligence as a predictor of overall survival in localized bladder cancer, a multicenter study.

Fiche publication

Date publication

décembre 2025

Journal

BMC cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Dr ESCHWEGE Pascal , Dr LAMBERT Aurélien

Tous les auteurs :
Blondeau A, Pitout A, Manuguerra A, Eschwege P, Mazeaud C, Lambert A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41382062

Résumé

Sarcopenia, characterized by a loss of skeletal muscle mass and function, is a poor prognosis risk factor in various cancers. Diagnosis typically involves quantifying skeletal muscle area at the L3 vertebral level (SMA) using CT imaging, however a universally accepted definition of sarcopenia does not exist.